Global PCR and NGS-Based Molecular Diagnostics Market Growth (Status and Outlook) 2025-2031

September 2025 | 119 pages | ID: G241327907A0EN
LP Information

Abstracts

According to this study, the global PCR and NGS-Based Molecular Diagnostics market size will reach US$ million by 2031.

United States market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key PCR and NGS-Based Molecular Diagnostics players cover Thermofisher, Illumine, Paragon Genomics, Roche, Qiagen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “PCR and NGS-Based Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world PCR and NGS-Based Molecular Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected PCR and NGS-Based Molecular Diagnostics sales for 2025 through 2031. With PCR and NGS-Based Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCR and NGS-Based Molecular Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global PCR and NGS-Based Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PCR and NGS-Based Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PCR and NGS-Based Molecular Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCR and NGS-Based Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCR and NGS-Based Molecular Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of PCR and NGS-Based Molecular Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Biomarker Discovery
• Blood Sample Testig
• Others

Segmentation by Application:

• Hospitals
• Academics/Research Institutions
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermofisher
• Illumine
• Paragon Genomics
• Roche
• Qiagen
• Bioo Scientific
• Agilent
• Pillar Biosciences
• LC-Bio Technologies (Hangzhou) CO. LTD.
• iGen Technologies
• Burning Rock

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global PCR and NGS-Based Molecular Diagnostics Market Size (2020-2031)
  2.1.2 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for PCR and NGS-Based Molecular Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 PCR and NGS-Based Molecular Diagnostics Segment by Type
  2.2.1 Biomarker Discovery
  2.2.2 Blood Sample Testig
  2.2.3 Others
2.3 PCR and NGS-Based Molecular Diagnostics Market Size by Type
  2.3.1 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2020-2025)
2.4 PCR and NGS-Based Molecular Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Academics/Research Institutions
  2.4.3 Others
2.5 PCR and NGS-Based Molecular Diagnostics Market Size by Application
  2.5.1 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2020-2025)

3 PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Player
  3.1.1 Global PCR and NGS-Based Molecular Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global PCR and NGS-Based Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PCR AND NGS-BASED MOLECULAR DIAGNOSTICS BY REGION

4.1 PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025)
4.2 Global PCR and NGS-Based Molecular Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas PCR and NGS-Based Molecular Diagnostics Market Size Growth (2020-2025)
4.4 APAC PCR and NGS-Based Molecular Diagnostics Market Size Growth (2020-2025)
4.5 Europe PCR and NGS-Based Molecular Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025)
5.2 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025)
5.3 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025)
6.2 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025)
6.3 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics by Region (2020-2025)
8.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET FORECAST

10.1 Global PCR and NGS-Based Molecular Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global PCR and NGS-Based Molecular Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas PCR and NGS-Based Molecular Diagnostics Forecast
  10.1.3 APAC PCR and NGS-Based Molecular Diagnostics Forecast
  10.1.4 Europe PCR and NGS-Based Molecular Diagnostics Forecast
  10.1.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Forecast
10.2 Americas PCR and NGS-Based Molecular Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.2.2 Canada Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.2.3 Mexico Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.2.4 Brazil Market PCR and NGS-Based Molecular Diagnostics Forecast
10.3 APAC PCR and NGS-Based Molecular Diagnostics Forecast by Region (2026-2031)
  10.3.1 China PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.3.2 Japan Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.3.3 Korea Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.3.4 Southeast Asia Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.3.5 India Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.3.6 Australia Market PCR and NGS-Based Molecular Diagnostics Forecast
10.4 Europe PCR and NGS-Based Molecular Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.4.2 France Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.4.3 UK Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.4.4 Italy Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.4.5 Russia Market PCR and NGS-Based Molecular Diagnostics Forecast
10.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.5.2 South Africa Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.5.3 Israel Market PCR and NGS-Based Molecular Diagnostics Forecast
  10.5.4 Turkey Market PCR and NGS-Based Molecular Diagnostics Forecast
10.6 Global PCR and NGS-Based Molecular Diagnostics Forecast by Type (2026-2031)
10.7 Global PCR and NGS-Based Molecular Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market PCR and NGS-Based Molecular Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermofisher
  11.1.1 Thermofisher Company Information
  11.1.2 Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offered
  11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Thermofisher Main Business Overview
  11.1.5 Thermofisher Latest Developments
11.2 Illumine
  11.2.1 Illumine Company Information
  11.2.2 Illumine PCR and NGS-Based Molecular Diagnostics Product Offered
  11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Illumine Main Business Overview
  11.2.5 Illumine Latest Developments
11.3 Paragon Genomics
  11.3.1 Paragon Genomics Company Information
  11.3.2 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offered
  11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Paragon Genomics Main Business Overview
  11.3.5 Paragon Genomics Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche PCR and NGS-Based Molecular Diagnostics Product Offered
  11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 Qiagen
  11.5.1 Qiagen Company Information
  11.5.2 Qiagen PCR and NGS-Based Molecular Diagnostics Product Offered
  11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Qiagen Main Business Overview
  11.5.5 Qiagen Latest Developments
11.6 Bioo Scientific
  11.6.1 Bioo Scientific Company Information
  11.6.2 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offered
  11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Bioo Scientific Main Business Overview
  11.6.5 Bioo Scientific Latest Developments
11.7 Agilent
  11.7.1 Agilent Company Information
  11.7.2 Agilent PCR and NGS-Based Molecular Diagnostics Product Offered
  11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Agilent Main Business Overview
  11.7.5 Agilent Latest Developments
11.8 Pillar Biosciences
  11.8.1 Pillar Biosciences Company Information
  11.8.2 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offered
  11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Pillar Biosciences Main Business Overview
  11.8.5 Pillar Biosciences Latest Developments
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
  11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Information
  11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offered
  11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Main Business Overview
  11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Latest Developments
11.10 iGen Technologies
  11.10.1 iGen Technologies Company Information
  11.10.2 iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offered
  11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 iGen Technologies Main Business Overview
  11.10.5 iGen Technologies Latest Developments
11.11 Burning Rock
  11.11.1 Burning Rock Company Information
  11.11.2 Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offered
  11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Burning Rock Main Business Overview
  11.11.5 Burning Rock Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. PCR and NGS-Based Molecular Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Biomarker Discovery
Table 4. Major Players of Blood Sample Testig
Table 5. Major Players of Others
Table 6. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Table 9. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Table 12. Global PCR and NGS-Based Molecular Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Player (2020-2025)
Table 14. PCR and NGS-Based Molecular Diagnostics Key Players Head office and Products Offered
Table 15. PCR and NGS-Based Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 20. Global PCR and NGS-Based Molecular Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country (2020-2025)
Table 24. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Table 26. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Table 28. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 30. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country (2020-2025)
Table 34. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of PCR and NGS-Based Molecular Diagnostics
Table 40. Key Market Challenges & Risks of PCR and NGS-Based Molecular Diagnostics
Table 41. Key Industry Trends of PCR and NGS-Based Molecular Diagnostics
Table 42. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Thermofisher Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 47. Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offered
Table 48. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Thermofisher Main Business
Table 50. Thermofisher Latest Developments
Table 51. Illumine Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 52. Illumine PCR and NGS-Based Molecular Diagnostics Product Offered
Table 53. Illumine PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Illumine Main Business
Table 55. Illumine Latest Developments
Table 56. Paragon Genomics Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 57. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offered
Table 58. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Paragon Genomics Main Business
Table 60. Paragon Genomics Latest Developments
Table 61. Roche Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 62. Roche PCR and NGS-Based Molecular Diagnostics Product Offered
Table 63. Roche PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Roche Main Business
Table 65. Roche Latest Developments
Table 66. Qiagen Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 67. Qiagen PCR and NGS-Based Molecular Diagnostics Product Offered
Table 68. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Qiagen Main Business
Table 70. Qiagen Latest Developments
Table 71. Bioo Scientific Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 72. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offered
Table 73. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Bioo Scientific Main Business
Table 75. Bioo Scientific Latest Developments
Table 76. Agilent Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 77. Agilent PCR and NGS-Based Molecular Diagnostics Product Offered
Table 78. Agilent PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Agilent Main Business
Table 80. Agilent Latest Developments
Table 81. Pillar Biosciences Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 82. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offered
Table 83. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Pillar Biosciences Main Business
Table 85. Pillar Biosciences Latest Developments
Table 86. LC-Bio Technologies (Hangzhou) CO. LTD. Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 87. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offered
Table 88. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. LC-Bio Technologies (Hangzhou) CO. LTD. Main Business
Table 90. LC-Bio Technologies (Hangzhou) CO. LTD. Latest Developments
Table 91. iGen Technologies Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 92. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offered
Table 93. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. iGen Technologies Main Business
Table 95. iGen Technologies Latest Developments
Table 96. Burning Rock Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 97. Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offered
Table 98. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Burning Rock Main Business
Table 100. Burning Rock Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. PCR and NGS-Based Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. PCR and NGS-Based Molecular Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. PCR and NGS-Based Molecular Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. PCR and NGS-Based Molecular Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type in 2024
Figure 10. PCR and NGS-Based Molecular Diagnostics in Hospitals
Figure 11. Global PCR and NGS-Based Molecular Diagnostics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. PCR and NGS-Based Molecular Diagnostics in Academics/Research Institutions
Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market: Academics/Research Institutions (2020-2025) & ($ millions)
Figure 14. PCR and NGS-Based Molecular Diagnostics in Others
Figure 15. Global PCR and NGS-Based Molecular Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 16. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas PCR and NGS-Based Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC PCR and NGS-Based Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe PCR and NGS-Based Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas PCR and NGS-Based Molecular Diagnostics Value Market Share by Country in 2024
Figure 24. United States PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries PCR and NGS-Based Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries PCR and NGS-Based Molecular Diagnostics Market Size 2026-2031 ($ millions)